Physician profile

Anitha Angan

Pulmonary Disease · San Ramon, CA

NPI 1528261500

$7,739.03

in general payments reported to CMS, 2019-2025

50 companies · $1,297 in 2025

The $1,297 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$3,606.73
Education$271.62

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Astrazeneca Pharmaceuticals Lp $1,493.14 2019-2025 Breztri, Fasenra, Tezspire
Glaxosmithkline, LLC. $1,325.72 2019-2025 Nucala, Trelegy Ellipta
Boehringer Ingelheim Pharmaceuticals, INC. $719.51 2019-2025 Ofev, Jardiance, Jascayd
Regeneron Healthcare Solutions, INC. $431.94 2021-2025 Dupixent
Janssen Pharmaceuticals, INC $411.78 2019-2023 Xarelto
Mylan Specialty L.P. $332.26 2019-2024 Yupelri
Sunovion Pharmaceuticals INC. $329.51 2019-2022
Genzyme Corporation $275.35 2020-2025
Sanofi-Aventis U.S. LLC $219.98 2022-2025
Amgen INC. $197.06 2021-2025 Tezspire, Krystexxa
Inspire Medical Systems, INC. $181.74 2025 Inspire
Baxter Healthcare $106.60 2022-2025 Hillrom - Monarch Airway Clearance System, Hillrom - Life 2000 Ventilation System
Inari Medical, INC. $104.50 2025 Flowtriever Catheter, S, Ct Thrombectomy System Kit
Novo Nordisk INC $101.92 2022-2023 Ozempic, Wegovy, Rybelsus
Advanced Respiratory, INC $99.73 2020-2021
Show all 50 companies
CompanyGeneral paymentsYearsTop products
Abbvie INC. $98.78 2020-2022
Sumitomo Pharma America, INC. $88.52 2023-2024 Gemtesa
Salix Pharmaceuticals, A Division of Bausch Health US, LLC $76.64 2021-2023 Xifaxan
Nestle Healthcare Nutrition INC. $74.68 2020-2023
Verona Pharma, INC. $74.17 2025 Ohtuvayre
Philips North America LLC $67.16 2022-2023
Pfizer INC. $65.44 2019-2023
Insmed, INC. $63.76 2021-2025 Arikayce
Novartis Pharmaceuticals Corporation $58.84 2021-2022
Allergan, INC. $50.90 2020
Avanir Pharmaceuticals, INC. $50.19 2019-2021
Takeda Pharmaceuticals U.S.A., INC. $49.96 2023-2024 Glassia, Cuvitru
Stryker Corporation $40.35 2025 Flowtriever
Sun Pharmaceutical Industries INC. $39.70 2020-2021
Gilead Sciences, INC. $38.52 2022-2023 Veklury
Medical Device Business Services, INC. $36.83 2024 Monarch
Acacia Pharma INC $36.56 2021
Eisai INC. $33.96 2021
Alexion Pharmaceuticals, INC. $33.70 2025 Ultomiris
Genentech USA, INC. $32.28 2019-2021
Exact Sciences Corporation $30.84 2024 Cologuard Collection Kit
Abiomed $29.30 2024 Impella
Actelion Pharmaceuticals US, INC. $26.06 2022
Mallinckrodt Hospital Products INC. $24.51 2025 Acthar
Vivus LLC $21.97 2022
Teva Pharmaceuticals USA, INC. $19.49 2023 Airduo Digihaler
Pulmonx Corporation $18.78 2025 Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Chartis Catheter
Inogen, INC. $18.48 2023 Inogen One G5 Oxygen Concentrator - Bluetooth
Paratek Pharmaceuticals, INC. $17.62 2020
Electromed, INC. $17.36 2024 Smartvest
Neurocrine Biosciences, INC. $17.03 2022
Merck Sharp & Dohme LLC $15.48 2022
Circassia INC. $14.80 2019
Otsuka America Pharmaceutical, INC. $14.42 2023 Nuedexta
Astellas Pharma US INC $11.21 2020

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Anitha Angan

$7,739.03

in general payments reported 2019-2025

Years
2019-2025
Top company
Astrazeneca Pharmaceuticals Lp
Context
The $1,297 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).

https://glasscript.com/doctor/68665/anitha-angan

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.